PMFA
CMD

Plante Moran Financial Advisors’s Cantel Medical Corporation CMD Stock Holding History

Plante Moran Financial Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$2K – 1039
2020
Q3 		$2K Buy
+40
New +$1.97K ﹤0.01% 797

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Plante Moran Financial Advisors's CMD Position: Q4 2020 in Review

Plante Moran Financial Advisors sold out of Cantel Medical Corporation (CMD) in Q4 2020, closing a stake of 40 shares — an estimated $2K sold.

Plante Moran Financial Advisors first reported a position in CMD in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Plante Moran Financial Advisors reported no remaining Cantel Medical Corporation position as of Q4 2020 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 40 Cantel Medical Corporation shares in Q4 2020, an estimated $2K.
  • Plante Moran Financial Advisors first reported a position in Cantel Medical Corporation in Q3 2020 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Cantel Medical Corporation position peaked at $2K in Q3 2020.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.